StonvexLoading…
StonvexStonvexStonvexCore line items from NGL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Annual 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $2.21B | $1.30B | $622.16M | $3.47B |
Operating Income | $301.35M | $191.70M | $97.45M | $329.36M |
Net Income | $145.38M | $98.21M | $68.92M | $39.37M |
EPS (Diluted) | Not available | Not available | Not available | Not available |
Total Assets | $4.38B | $4.30B | $4.19B | $4.61B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $6.48M | $8.66M | $5.44M | $5.65M |
Free Cash Flow OCF − CapEx | $66.30M | $20.59M | $11.07M | $51.65M |
Shares Outstanding | Not available | Not available | Not available | Not available |